Skip to content

What We Do
Meet Our Team
Contact Us

What We Do
Meet Our Team
Contact Us

Clients in the Media

Found 4 Results

November 4, 2025 | Sparrow Pharmaceutials

BIO-Europe 2025: Sparrow Pharmaceuticals raised a $95M series B last month – it will be testing its cortisol depleting HSD1 inhibitor in treatment-resistant type 2 diabetes

BiotechTV

September 24, 2025 | Sparrow Pharmaceutials

RA and Forbion back Sparrow’s $95M Series B for type 2 diabetes drug

Endpoints

September 24, 2025 | Sparrow Pharmaceutials

Finance Watch: Sparrow Flies Into Late-Stage Development With $95m Financing

Scrip + Citeline

September 24, 2025 | Sparrow Pharmaceutials

Sparrow flies forward with the $95M series B for midstage diabetes asset

Fierce Biotech

LifeSci Communications is the strategic communications partner for life science innovators to tell their stories and engage audiences that drive every stage of growth. From branding and positioning to media relations and digital strategy, LifeSci Communications ensures every effort advances client goals and executes corporate and product-focused programs with a commitment to accuracy, authenticity, and ambition. We are the communications agency your science demands.

New York City Headquarters
1700 Broadway, 40th Floor,
New York, NY 10019
Phone: (646) 889-1200

Boston
One International Place,
Suite 1480
Boston, MA 02110

San Diego
2869 Historic Decatur Rd
San Diego, CA 92106

What We Do
Meet Our Team
Contact Us

The business verticals within the LifeSci platform collectively provide companies with the resources and experience they need to realize the full potential of their scientific innovation, driving long-term value for shareholders and patients.

LifeSci Advisors
LifeSci Capital
LifeSci Consulting
LifeSci Events
LifeSci Search
LifeSci Venture

Copyright © 2026 LifeSci Communications | All Rights Reserved

Privacy Policy
Accessibility Statement
Disclaimer
Cookie Policy